William J. Chiou
AbbVie (United States)(US)
Publications by Year
Research Areas
Nitric Oxide and Endothelin Effects, Receptor Mechanisms and Signaling, Electron Spin Resonance Studies, Hormonal Regulation and Hypertension, Eicosanoids and Hypertension Pharmacology
Most-Cited Works
- → Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome(2006)906 cited
- → Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist.(1996)209 cited
- → 2,4-Diarylpyrrolidine-3-carboxylic AcidsPotent ETA Selective Endothelin Receptor Antagonists. 1. Discovery of A-127722(1996)110 cited
- → Simultaneous quantification of malonyl-CoA and several other short-chain acyl-CoAs in animal tissues by ion-pairing reversed-phase HPLC/MS(2007)101 cited
- → Pyrrolidine-3-carboxylic Acids as Endothelin Antagonists. 4. Side Chain Conformational Restriction Leads to ETB Selectivity(1999)90 cited
- → Discovery and Metabolic Stabilization of Potent and Selective 2-Amino-N-(adamant-2-yl) Acetamide 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors(2006)77 cited
- → Endothelin Stimulates Glucose Uptake and GLUT4 Translocation via Activation of Endothelin ETA Receptor in 3T3-L1 Adipocytes(1999)76 cited
- → Oxidant-Induced Activation of Protein Kinase C in Uc11mg Cells(1995)73 cited
- → New Antimitotic Agents with Activity in Multi-Drug-Resistant Cell Lines and in Vivo Efficacy in Murine Tumor Models(2001)66 cited
- → Adamantane sulfone and sulfonamide 11-β-HSD1 Inhibitors(2006)64 cited